Prognos Health

Query billions of fully-integrated lab & health records on more than 325M de-identified patients to answer key healthcare questions in minutes on prognosFACTOR.

[Prognos Health @prognosAI]

Just In: evidence shows the need for an RWD paradigm shift in pharma. Check out our latest infographic to learn more. https://t.co/loDWEaTfnh
#RWDmarketplace #realworlddata

[Prognos Health @prognosAI]

In our recent panel discussion “How to determine your next best action for every HCP engagement”, leaders from Novartis, GSK, and Takeda Oncology discussed their #RWD strategies to commercialize drug therapies. 3 important best practices were revealed. https://t.co/nkPng25r6t

[Prognos Health @prognosAI]

68% of #pharma leaders believe the way #lifescience companies currently purchase patient-level data is ripe for disruption.

Find out what challenges dominate current #RWD efforts and how technology can help address them.

https://t.co/VhPFQKwswT

#RealWorldData

[Prognos Health @prognosAI]

Therapy-related #RWD insights and learnings for a new brand launch can take 12-18 months. One leading #pharma company cut this time in half. Find out how.
https://t.co/dqrmQWS3GN

#Omnichannel #Oncology #Pharmaceutical #TherapyLaunch #RealWorldData

[Prognos Health @prognosAI]

In a recent survey of #pharma leaders by Reuters, 68% of respondents believe the way #LifeSciences companies currently purchase patient-level data is ripe for disruption.

Find out what challenges dominate current #RWD efforts and how technology can help.

https://t.co/qdVSP27IND

[Prognos Health @prognosAI]

Dr. Steven Zatz Joins Prognos Health Board of Directors

"Steve’s vision and leadership helped build WebMD into an iconic healthcare brand," says @sundeepbhan1.

https://t.co/apRWUX9TK4

[Prognos Health @prognosAI]

More than 300M people worldwide are living with a #RareDisease. Every day, Prognos is committed to improving the lives of those impacted.

See how one pharma company helped fight rare disease with RWD analysis: https://t.co/W7CDYrDi5x

Let's raise awareness and generate change.

[Prognos Health @prognosAI]

Inflated healthcare costs have made accurate risk prediction more
important than ever for underwriters. Luckily, there’s an AI-driven solution that can help. Read our latest blog to discover how. https://t.co/pcu0aKDKea

#underwritingriskprediction #healthcareunderwriting

[Prognos Health @prognosAI]

Has a lack of resources ever hindered your company from
commercial success? An end-to-end RWD solution can help. https://t.co/ciD3lDpOeh
#RWDanalytics #drugcommercialization

[Prognos Health @prognosAI]

AI-driven risk prediction: A powerful underwriting tool in an era of high inflation. Learn how you can utilize it in our latest blog. https://t.co/npL2VPLcJ8

#underwritingriskprediction #healthcareunderwriting

[Prognos Health @prognosAI]

Prognos Health Named to NYC Digital Health 100 by @NYCHBL

https://t.co/d85OQdirWy

#DigitalHealth #RWD #RWDInsights #RWDMarketplace

[Prognos Health @prognosAI]

Prevent the failure of your next drug launch with an end-to-end
real-world data solution. https://t.co/tPpMiW0oMt
#RWDanalytics #drugcommercialization

[Prognos Health @prognosAI]

68% of survey respondents believe the way their companies purchase patient-level #data is ripe for disruption. Discover what other peer insights were revealed in the recent Reuters survey of #pharmaceutical leaders. Download the whitepaper to find out. https://t.co/utqwvCGdB5

[Prognos Health @prognosAI]

Reuters surveyed pharma professionals to uncover their top 10
challenges when it comes to real-world data processes. The findings? Hint: They all point towards the need for a disruption in the status quo. https://t.co/xcyeCArarz
#RWDmarketplace #realworlddata

[Prognos Health @prognosAI]

Results from a new Reuters survey shows a status quo of patient data collection in pharma that is expensive, time-consuming, and ripe for disruption. How do we address these issues? Find out here. https://t.co/4OOTWY57dL

#RWDmarketplace #realworlddata

[Prognos Health @prognosAI]

Reuters surveyed more than 200 pharmaceutical leaders to determine real-world data (RWD) usage trends for therapy commercialization. What peer insights were revealed? Download the whitepaper to find out. https://t.co/sARfhCRtPb

#RWDmarketplace #realworlddata

[Prognos Health @prognosAI]

It’s no secret that small & midsize pharma companies don’t have access to the same amount of resources as big pharma. You can level the playing field by utilizing an end-to-end RWD analytics solution. Discover how you can benefit and download the eBook. https://t.co/exMQDwLhrW

[Prognos Health @prognosAI]

Looking to improve your risk prediction accuracy? We’ve got you covered. Check out our 5 step guide to help you do so. Download now.

https://t.co/DBTzB2CLw2

#underwritinghealthrisk #healthcareunderwriting

[Prognos Health @prognosAI]

Small or midsize pharma company? Level the playing field with big pharma through an end-to-end RWD solution. Read on. https://t.co/5hI2eQ2iay

#RWDmarketing #pharmabrandlaunch

[Prognos Health @prognosAI]

Survey, Whitepaper from Prognos Health and @RE_Pharma Uncovers RWD Trends in the Pharmaceutical Industry. https://t.co/FRoD72gyWc

#RealWorldData #RWDMarketplace #Pharma